Implications of the obesity epidemic for lipid-lowering therapy: Non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target
Michel R HoenigRoyal Brisbane and Women’s Hospital, Herston, Queensland, AustraliaAbstract: Obesity, metabolic syndrome and diabetes are conditions with increasing prevalence around the world. Cardiovascular risk in diabetics is often so high as to overlap with event rates observed in thos...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-02-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/implications-of-the-obesity-epidemic-for-lipid-lowering-therapy-non-hd-peer-reviewed-article-VHRM |